These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 19770831)
1. [Cavinton in the complex treatment of patients with chronic cerebrovascular insufficiency]. Chukanova EI Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(9):35-9. PubMed ID: 19770831 [TBL] [Abstract][Full Text] [Related]
2. [The use of cavinton in the therapy of cognitive disorders in patients with discirculatory encephalopathy]. Odinak MM; Lobzin VIu Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(10):63-4. PubMed ID: 20213894 [No Abstract] [Full Text] [Related]
3. [A multicenter program on assessment of efficacy and safety of a new therapeutic scheme for patients with chronic cerebrovascular insufficiency]. Skoromets AA; Tanashian MM; Chukanova EI; Petrova EA; Spirin NN; Nikonov AA; Peverennova IE; Levin IaI Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(5 Suppl 2):44-8. PubMed ID: 19894300 [TBL] [Abstract][Full Text] [Related]
4. [Efficacy of cavinton in the treatment of patients with chronic blood flow insufficiency. Russian multicenter clinical-epidemiological program "CALIPSO"]. Chukanova EI Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(12):49-52. PubMed ID: 21311488 [TBL] [Abstract][Full Text] [Related]
5. [The use of the combined drug vinpotropil at early stages of cerebrovascular insufficiency]. Zakharov VV; Lokshina AB; Stakhovskaia LV; Timerbaeva SL; Lagoda OV Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(9):76-8. PubMed ID: 18686371 [No Abstract] [Full Text] [Related]
6. [Treatment of circulatory encephalopathy with Cavinton]. Lebedeva NV; Chukhrova VA; Solov'ev OU; Nepesov RR Klin Med (Mosk); 1997; 75(11):51-3. PubMed ID: 9490359 [No Abstract] [Full Text] [Related]
7. [Effect of cavinton on the hemorheological parameters of chronic cerebrovascular patients]. Sapary L; Horvath B; Alexy T; Marton Z; Kesmarky G; Zsots M; Nagy F; Czopf I; Toth K Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(6):47-51. PubMed ID: 16841484 [No Abstract] [Full Text] [Related]
8. [Vinpotropile in the treatment of cerebral vascular diseases]. Filimonov VA; Kliueva VN; Kondrasheva IN Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(2):58-60. PubMed ID: 18689000 [No Abstract] [Full Text] [Related]
9. [Effect of cavinton on systemic and cerebral hemodynamics of patients with chronic cerebral circulatory insufficiency]. Ishchenko MM; Shkrobot SI Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(9):1338-42. PubMed ID: 4072532 [TBL] [Abstract][Full Text] [Related]
10. [Possibilities of cavinton therapy regimen for infusions and cavinton comforte in acute and early recovery periods after ischemic stroke]. Belova LA; Mashin VV; Proshin AN; Ovsyannicova AN; Kostishko BB Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(9):51-58. PubMed ID: 29053121 [TBL] [Abstract][Full Text] [Related]
11. [Cavinton forte treatment of cerebral vascular insufficiency in patients with coronary heart disease and arterial hypertension]. Protasov KV; Dzizinskiĭ AA; Shprakh VV; Sinkevich DA; Kuklin SG; Filatova LN Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(7):31-4. PubMed ID: 16921716 [TBL] [Abstract][Full Text] [Related]
12. [Diagnostics and treatment tactics for chronic cerebrovascular disorders with the use of single photon emission computed tomography]. Murashko NK Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(1):51-5. PubMed ID: 18427520 [TBL] [Abstract][Full Text] [Related]
13. [Effectiveness of using cavinton in patients of different ages with chronic forms of cerebrovascular diseases (clinico-rheographic research)]. Burtsev EM; Shprakh VV; Savkov VS Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(1):39-44. PubMed ID: 3364094 [TBL] [Abstract][Full Text] [Related]
14. [An effect of vinpocetine (cavinton) on endothelium function in patients with chronic cerebral ischemia]. Vaizova OE; Vengerovskiĭ AI; Alifirova VM Zh Nevrol Psikhiatr Im S S Korsakova; 2006; Suppl 16():46-50. PubMed ID: 18196635 [TBL] [Abstract][Full Text] [Related]
15. [About cavinton therapy of the patients with brain vascular diseases]. Nikitina VV; Pravdina AN; Zapatrina OV Voen Med Zh; 2007 Feb; 328(2):43-5. PubMed ID: 17508611 [No Abstract] [Full Text] [Related]
16. Rheoencephalographic and psychological studies with ethyl apovincaminate in cerebral vascular insufficiency. Hadjiev D; Yancheva S Arzneimittelforschung; 1976; 26(10a):1947-50. PubMed ID: 1037222 [TBL] [Abstract][Full Text] [Related]
17. [Trial of using Cavinton in cerebrovascular disorders]. Shtok VN; Eremeeva SV Klin Med (Mosk); 1982 Oct; 60(10):39-42. PubMed ID: 6757560 [No Abstract] [Full Text] [Related]
18. [Use of sermion, Cavinton and trental in patients with cerebrovascular disorders]. Lebedeva NV; Khrapova EV Sov Med; 1990; (1):60-3. PubMed ID: 2190329 [No Abstract] [Full Text] [Related]
19. [Effect of cavinton and sulfocamphocain on systemic and cerebral hemodynamics in patients with early forms of cerebrovascular diseases]. Ishchenko MM; Shkrobot SI; Borak VT Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(8):1160-4. PubMed ID: 3673409 [TBL] [Abstract][Full Text] [Related]
20. [The multimodal strategy for the neuroprotection in stroke: results of the Russian multicenter clinical-epidemiological program SOKOL]. Tabeeva GR; Azimova IuE Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(12 Pt 2):20-30. PubMed ID: 23388602 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]